The University of Houston College of Medicine has received a $3 million gift that will fund one year's worth of tuition for its inaugural class, in today's bite-sized hospital and health industry news from Florida, North Carolina, and Texas.
- Florida: The St. Petersburg Free Clinic for uninsured patients is in need of volunteer nurses. The clinic said that its current staffing levels have meant it's had to limit the number of patients it sees. Susan Beaven, a physician at the clinic said that without nurses, the clinic "wouldn't have a role for the physicians because we need the nursing support" (Lane, WFTS, 7/18).
- North Carolina: Granville Health System has named John Snow as CEO, effective Aug. 13. Snow most recently served as the VP of ancillary and support services at Iredell Health System in Statesville, and has previously served as the CEO of Blue Ridge Community Health Services in Hendersonville and as CEO of Spalding Regional Medical Center in Georgia. Snow succeeds L. Lee Isley, who left Granville to become CEO of Nash UNC Health Care in North Carolina (Vaidya, Becker's Hospital Review, 7/18).
- Texas: The University of Houston College of Medicine has received an anonymous $3 million gift that will fund one year's worth of tuition for its inaugural class. Renu Khator, president of the University, said the gift of a year's worth of no-cost tuition "will allow [medical] students an opportunity to attend [the UH College of Medicine] and ultimately lead the future medical workforce" (Pulsinelli, Houston Business Journal, 7/18).
How to attract millennial nurses—and keep them happy
In 2016, millennials surpassed Baby Boomers as the largest living generation in the United States. As more millennials have entered the nursing workforce, health care leaders have confronted a growing challenge: young nurses are turning over at higher rates than their older peers, especially early in their careers.
Use the strategies and best practices in this study to build a millennial-specific retention strategy for your organization.
Download the Report
Next in the Daily Briefing
Two studies raise CRISPR-related cancer concerns—but experts say the technology isn't doomed